Pharmacies in informal settlements: a retrospective, cross-sectional household and health facility survey in four countries.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
09 Sep 2021
Historique:
received: 08 06 2021
accepted: 19 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 14 9 2021
Statut: epublish

Résumé

Slums or informal settlements characterize most large cities in LMIC. Previous evidence suggests pharmacies may be the most frequently used source of primary care in LMICs but that pharmacy services are of variable quality. However, evidence on pharmacy use and availability is very limited for slum populations. We conducted household, individual, and healthcare provider surveys and qualitative observations on pharmacies and pharmacy use in seven slum sites in four countries (Nigeria, Kenya, Pakistan, and Bangladesh). All pharmacies and up to 1200 households in each site were sampled. Adults and children were surveyed about their use of healthcare services and pharmacies were observed and their services, equipment, and stock documented. We completed 7692 household and 7451 individual adults, 2633 individual child surveys, and 157 surveys of pharmacies located within the seven sites. Visit rates to pharmacies and drug sellers varied from 0.1 (Nigeria) to 3.0 (Bangladesh) visits per person-year, almost all of which were for new conditions. We found highly variable conditions in what constituted a "pharmacy" across the sites and most pharmacies did not employ a qualified pharmacist. Analgesics and antibiotics were widely available but other categories of medications, particularly those for chronic illness were often not available anywhere. The majority of pharmacies lacked basic equipment such as a thermometer and weighing scales. Pharmacies are locally and widely available to residents of slums. However, the conditions of the facilities and availability of medicines were poor and prices relatively high. Pharmacies may represent a large untapped resource to improving access to primary care for the urban poor.

Sections du résumé

BACKGROUND BACKGROUND
Slums or informal settlements characterize most large cities in LMIC. Previous evidence suggests pharmacies may be the most frequently used source of primary care in LMICs but that pharmacy services are of variable quality. However, evidence on pharmacy use and availability is very limited for slum populations.
METHODS METHODS
We conducted household, individual, and healthcare provider surveys and qualitative observations on pharmacies and pharmacy use in seven slum sites in four countries (Nigeria, Kenya, Pakistan, and Bangladesh). All pharmacies and up to 1200 households in each site were sampled. Adults and children were surveyed about their use of healthcare services and pharmacies were observed and their services, equipment, and stock documented.
RESULTS RESULTS
We completed 7692 household and 7451 individual adults, 2633 individual child surveys, and 157 surveys of pharmacies located within the seven sites. Visit rates to pharmacies and drug sellers varied from 0.1 (Nigeria) to 3.0 (Bangladesh) visits per person-year, almost all of which were for new conditions. We found highly variable conditions in what constituted a "pharmacy" across the sites and most pharmacies did not employ a qualified pharmacist. Analgesics and antibiotics were widely available but other categories of medications, particularly those for chronic illness were often not available anywhere. The majority of pharmacies lacked basic equipment such as a thermometer and weighing scales.
CONCLUSIONS CONCLUSIONS
Pharmacies are locally and widely available to residents of slums. However, the conditions of the facilities and availability of medicines were poor and prices relatively high. Pharmacies may represent a large untapped resource to improving access to primary care for the urban poor.

Identifiants

pubmed: 34503501
doi: 10.1186/s12913-021-06937-9
pii: 10.1186/s12913-021-06937-9
pmc: PMC8431901
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

945

Investigateurs

Pauline Bakibinga (P)
Caroline Kabaria (C)
Ziraba Kasiira (Z)
Peter Kibe (P)
Catherine Kyobutungi (C)
Nelson Mbaya (N)
Blessing Mberu (B)
Shukri Mohammed (S)
Anne Njeri (A)
Iqbal Azam (I)
Romaina Iqbal (R)
Ahsana Nazish (A)
Narijis Rizvi (N)
Syed A K Shifat Ahmed (SAK)
Nazratun Choudhury (N)
Ornob Alam (O)
Afreen Zaman Khan (AZ)
Omar Rahman (O)
Rita Yusuf (R)
Doyin Odubanjo (D)
Motunrayo Ayobola (M)
Olufunke Fayehun (O)
Akinyinka Omigbodun (A)
Mary Osuh (M)
Eme Owoaje (E)
Olalekan Taiwo (O)
Richard J Lilford (RJ)
Jo Sartori (J)
Samuel I Watson (SI)
Peter J Diggle (PJ)
Navneet Aujla (N)
Yen-Fu Chen (YF)
Paramjit Gill (P)
Frances Griffiths (F)
Bronwyn Harris (B)
Jason Madan (J)
Helen Muir (H)
Oyinlola Oyebode (O)
Vangelis Pitidis (V)
João Porto de Albuquerque (JP)
Simon Smith (S)
Celia Taylor (C)
Philip Ulbrich (P)
Olalekan A Uthman (OA)
Ria Wilson (R)
Godwin Yeboah (G)

Informations de copyright

© 2021. The Author(s).

Références

Pharm World Sci. 2009 Jun;31(3):351-61
pubmed: 19343530
Lancet. 2017 Feb 4;389(10068):547-558
pubmed: 27760703
Int J Health Policy Manag. 2020 Nov 09;:
pubmed: 33201652
BMC Med Res Methodol. 2019 May 30;19(1):109
pubmed: 31146676
Int J Qual Health Care. 2010 Aug;22(4):316-23
pubmed: 20430823
Front Public Health. 2021 Apr 30;9:628744
pubmed: 33996712
BMC Health Serv Res. 2012 Jul 27;12:223
pubmed: 22838649
Lancet. 2016 Aug 6;388(10044):613-21
pubmed: 27358250
Lancet. 2016 Aug 6;388(10044):622-30
pubmed: 27358252
J Clin Tuberc Other Mycobact Dis. 2019 Dec 02;18:100135
pubmed: 31872080
Health Policy Plan. 2016 Mar 8;31(7):940-953
pubmed: 26962123
Lancet. 2016 Aug 6;388(10044):596-605
pubmed: 27358253
J Public Health (Oxf). 2012 Jun;34(2):261-71
pubmed: 22241915
Lancet. 2017 Feb 4;389(10068):559-570
pubmed: 27760702
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33148540
Glob Health Action. 2014 Mar 27;7:23286
pubmed: 24679543
Front Med (Lausanne). 2017 Dec 07;4:218
pubmed: 29270407
Glob Health Sci Pract. 2013 Nov 08;1(3):328-56
pubmed: 25276548
BMJ Glob Health. 2019 Apr 11;4(2):e001267
pubmed: 31139443
Lancet. 2016 Aug 6;388(10044):606-12
pubmed: 27358251

Auteurs

Sam Watson (S)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK. s.i.watson@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH